Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · IEX Real-Time Price · USD
13.43
+0.66 (5.17%)
Jul 5, 2022 4:00 PM EDT - Market closed
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Market Capitalization
|
281 | 505 | 46 | 25 | 69 | 129 |
| Market Cap Growth
|
- | 992.91% | 82.44% | -63.32% | -46.34% | - |
| Enterprise Value
|
152 | 356 | 52 | -13 | 6 | 108 |
| PE Ratio
|
- | -4.56 | -10.34 | -1.09 | -6.64 | -5.75 |
| PS Ratio
|
85.05 | 450.53 | 3.17 | - | 3.42 | - |
| PB Ratio
|
2.26 | 3.70 | -3.71 | 0.69 | 1.18 | 7.38 |
| EV/Sales Ratio
|
45.96 | 306.99 | -0.07 | - | 0.01 | - |
| Debt / Equity Ratio
|
0.00 | 0.00 | -0.82 | 0.00 | 0 | 0 |
| Debt / EBITDA Ratio
|
0.00 | -0.01 | -4.13 | -0.01 | 0 | 0 |
| Debt / FCF Ratio
|
-0.02 | -0.03 | -0.81 | -0.01 | 0 | 0 |
| Current Ratio
|
11.78 | 9.90 | 0.62 | 11.87 | 11.73 | 5.82 |
| Asset Turnover
|
0.03 | 0.01 | 0.39 | 0 | 0.37 | 0 |
| Return on Equity (ROE)
|
-108.70% | -122.50% | -16.20% | -53.30% | -22.60% | -87.50% |
| Return on Assets (ROA)
|
-96.00% | -109.30% | -11.90% | -49.00% | -19.00% | -79.00% |
| Return on Capital (ROIC)
|
- | 2357.90% | 119.80% | 1465.10% | 139.20% | 1205.60% |
| Earnings Yield
|
-43.20% | -21.95% | -9.67% | -91.95% | -15.07% | -17.38% |
| FCF Yield
|
-13.60% | -4.45% | -27.51% | -95.19% | -8.47% | -14.69% |
| Buyback Yield / Dilution
|
-722.65% | -250.99% | 6.04% | -19.62% | -56.56% | -2441.82% |
| Total Shareholder Return
|
-722.65% | -250.99% | 6.04% | -19.62% | -56.56% | -2441.82% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).